Wempe MF - Search Results

1

New insights into the structure of (1→3,1→6)-β-D-glucan side chains in the Candida glabrata cell wall.

Lowman DW, West LJ, Bearden DW, Wempe MF, Power TD, Ensley HE, Haynes K, Williams DL, Kruppa MD. Lowman DW, et al. Among authors: wempe mf. PLoS One. 2011;6(11):e27614. doi: 10.1371/journal.pone.0027614. Epub 2011 Nov 11. PLoS One. 2011. PMID: 22096604 Free PMC article.

2

Differential high-affinity interaction of dectin-1 with natural or synthetic glucans is dependent upon primary structure and is influenced by polymer chain length and side-chain branching.

Adams EL, Rice PJ, Graves B, Ensley HE, Yu H, Brown GD, Gordon S, Monteiro MA, Papp-Szabo E, Lowman DW, Power TD, Wempe MF, Williams DL. Adams EL, et al. Among authors: wempe mf. J Pharmacol Exp Ther. 2008 Apr;325(1):115-23. doi: 10.1124/jpet.107.133124. Epub 2008 Jan 2. J Pharmacol Exp Ther. 2008. PMID: 18171906 Free article.

3

Investigating idebenone and idebenone linoleate metabolism: in vitro pig ear and mouse melanocyte studies.

Wempe MF, Lightner JW, Zoeller EL, Rice PJ. Wempe MF, et al. J Cosmet Dermatol. 2009 Mar;8(1):63-73. doi: 10.1111/j.1473-2165.2009.00426.x. J Cosmet Dermatol. 2009. PMID: 19250169

4

Pharmacokinetics of letrozole in male and female rats: influence of complexation with hydroxybutenyl-beta cyclodextrin.

Wempe MF, Buchanan CM, Buchanan NL, Edgar KJ, Hanley GA, Ramsey MG, Skotty JS, Rice PJ. Wempe MF, et al. J Pharm Pharmacol. 2007 Jun;59(6):795-802. doi: 10.1211/jpp.59.6.0006. J Pharm Pharmacol. 2007. PMID: 17637172

5

Stability of Extemporaneously Prepared Hydroxychloroquine Sulfate 25-mg/mL Suspensions in Plastic Bottles and Syringes.

McHenry AR, Wempe MF, Rice PJ. McHenry AR, et al. Among authors: wempe mf. Int J Pharm Compd. 2017 May-Jun;21(3):251-254. Int J Pharm Compd. 2017. PMID: 28557788

6

Inhibiting efflux with novel non-ionic surfactants: Rational design based on vitamin E TPGS.

Wempe MF, Wright C, Little JL, Lightner JW, Large SE, Caflisch GB, Buchanan CM, Rice PJ, Wacher VJ, Ruble KM, Edgar KJ. Wempe MF, et al. Int J Pharm. 2009 Mar 31;370(1-2):93-102. doi: 10.1016/j.ijpharm.2008.11.021. Epub 2008 Nov 30. Int J Pharm. 2009. PMID: 19100824

7

Metabolism and pharmacokinetic studies of JPH203, an L-amino acid transporter 1 (LAT1) selective compound.

Wempe MF, Rice PJ, Lightner JW, Jutabha P, Hayashi M, Anzai N, Wakui S, Kusuhara H, Sugiyama Y, Endou H. Wempe MF, et al. Drug Metab Pharmacokinet. 2012;27(1):155-61. doi: 10.2133/dmpk.dmpk-11-rg-091. Epub 2011 Sep 13. Drug Metab Pharmacokinet. 2012. PMID: 21914964 Free article.

8

Developing potent human uric acid transporter 1 (hURAT1) inhibitors.

Wempe MF, Jutabha P, Quade B, Iwen TJ, Frick MM, Ross IR, Rice PJ, Anzai N, Endou H. Wempe MF, et al. J Med Chem. 2011 Apr 28;54(8):2701-13. doi: 10.1021/jm1015022. Epub 2011 Mar 30. J Med Chem. 2011. PMID: 21449597 Free PMC article.

9

Potent human uric acid transporter 1 inhibitors: in vitro and in vivo metabolism and pharmacokinetic studies.

Wempe MF, Lightner JW, Miller B, Iwen TJ, Rice PJ, Wakui S, Anzai N, Jutabha P, Endou H. Wempe MF, et al. Drug Des Devel Ther. 2012;6:323-39. doi: 10.2147/DDDT.S35805. Epub 2012 Nov 8. Drug Des Devel Ther. 2012. PMID: 23152669 Free PMC article.

10

Human uric acid transporter 1 (hURAT1): an inhibitor structure-activity relationship (SAR) study.

Wempe MF, Quade B, Jutabha P, Iwen T, Frick M, Rice PJ, Wakui S, Endou H. Wempe MF, et al. Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1312-23. doi: 10.1080/15257770.2011.594031. Nucleosides Nucleotides Nucleic Acids. 2011. PMID: 22132992

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters